18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8993L | BGC-20-1531 hydrochloride(1186532-61-5 free base) | BGC-20-1531 hydrochloride,GTPL3380 hydrochloride,AP-1531 hydrochloride | Prostaglandin Receptor |
BGC-20-1531 hydrochloride(1186532-61-5 free base) (GTPL3380 hydrochloride) is a EP4 antagonist for the treatment of acute migraine. | |||
T13550 | AP5 | Others | |
AP5 is a potent and selective agonist for the GPR40 receptor with positive allosteric modulation of endogenous ligands (AgoPAM). AP5 demonstrates a rat hIP1 EC50 of 0.49 nM against the GPR40 receptor. | |||
T10930 | D-AP5 | D-APV,D-2-Amino-5-phosphonovaleric acid | NMDAR , iGluR |
D-AP5 (D-APV) is a NMDA receptor antagonist. | |||
T22733 | DL-AP5 | NMDAR | |
DL-AP5 is the racemic form of a selective N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant effects. | |||
T22909 | L-AP5 | Others | |
L-AP5 is a NMDA antagonist. | |||
T23081 | NPEC-caged-D-AP5 | Others | |
NPEC-caged-D-AP5 is a NMDA receptor antagonist. | |||
T22732 | DL-AP5 Sodium salt | Others | |
DL-AP5 Sodium salt is a NMDA receptor antagonist. | |||
T77570 | AP-C2 | PKA | |
AP-C2 is a potent small molecule guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) inhibitor with a pIC50 of 5.2 for cGKII. | |||
T60500 | AP-C5 | Parasite | |
AP-C5 is a compound with selective inhibition of guanosine 3',5' cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII), with a Pic50 value of 7.2 for cGMP, and can be used in the study of diarrheal diseases. | |||
T5416 | T-5224 | MMP | |
T-5224 is a transcription factor c-Fos/AP-1 inhibitor, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. | |||
TN1237 | 3-O-Methylgallic acid | 3,4-Dihydroxy-5-methoxybenzoic acid | Apoptosis , NF-κB , OCT , DNA/RNA Synthesis , STAT |
3-O-Methylgallic acid (3,4-Dihydroxy-5-methoxybenzoic acid) reduces cell proliferation in Caco-2 cells(IC50 = 24.1 μM) more effectively than anthocyanins and may offer protection against colon cancer after its formation ... | |||
T26640 | AP-521 (Free base) | AP-521,AP521,AP 521 | |
AP-521, a 5-HT1A receptor antagonist, is used potentially for the treatment of anxiety. | |||
T82990 | AP-C4 | ||
AP-C4 is a selective inhibitor targeting guanosine 3′,5′-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII), exhibiting a pIC50 value of 5.2. Conversely, AP-C3 does not inhibit cGKII-mediated anion secretion... | |||
T82991 | AP-C3 | ||
AP-C3 is a potent inhibitor of guanosine 3′,5′-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII), exhibiting a pIC50 value of 6.3 and demonstrating only weak inhibition of cGKII-dependent anion secretion [1... | |||
T82989 | AP-C6 | ||
AP-C6 is a potent inhibitor of guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII), exhibiting a pIC50 of 6.5. It inhibits human cGKII activity in vitro in a concentration-dependent manner and... | |||
T37969 | 12(S)-HpETE | ||
12(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of platelet or leukocyte 12-lipoxygenase (12-LO) on arachidonic acid. It activates human blood leukocyte 5-LO, resulting in the sy... | |||
T4700 | 1,3,5-Trihydroxy-4-prenylxanthone | ||
1,3,5-Trihydroxy-4-prenylxanthone is a relatively potent inhibitor of phosphodiesterase type 5 (PDE5), with an IC50 value of 3.0 μM; it shows in vitro inhibitory activity against acetylcholinesterase (AChE) and butyrylch... | |||
T35943 | 15(S)-HpETE | ||
15(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of 15-lipoxygenase (15-LO) on arachidonic acid. It is either metabolized to 14,15-leukotriene A4 [1] or reduced to 15(S)-HETE by ... |